Trehalose

Nagase Viita Co., Ltd. (Headquarters: Shimoishii, Kita-ku, Okayama; Representative Director: Naoki Yasuba), a member of the NAGASE Group, has launched...

Founded as a starch syrup manufacturer in 1883, Nagase Viita (Formerly Hayashibara Co., Ltd.)  has grown into a company with strong...

BioHale® is  DFE Pharma´s, high-purity, low-endotoxin product portfolio for the stabilization of biologics. Because stability matters. BioHale® Key promises: Uncompromised...

Reversible protein precipitates (protein microbeads) have been developed using Shirasu porous glass (SPG) membrane emulsification. Microbeads have a mean size...

Most of biopharmaceuticals, in their liquid form, are prone to instabilities during storage. In order to improve their stability, lyophilization...

Abstract Background Traumatic brain injury (TBI) is the most common cause of cognitive and behavioral deficits, disability, and mortality worldwide....

A dry powder inhaled liposomal azithromycin formulation was developed for the treatment of chronic respiratory diseases such as cystic fibrosis...

Successful oral delivery of liposomes requires formulations designed to withstand harsh gastrointestinal conditions, e.g., by converting to solid-state followed by...

Spray drying microencapsulation has emerged as a promising technique for producing highly active probiotic powders. The efficient delivery of live...

Over the last 15 years, spray drying (SD), as an alternative to lyophilization, to manufacture and increase the stability of...